BioV Eye supplement Plus Lutein Tablets
Natural health product licensed in Canada
- Other names
- ye supplement Plus LuteinTablets
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80067062
- Status
- Inactive licence
- Licence date
- 19 February 2016
- Revision date
- 18 May 2022
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 200 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 40 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 40 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sélénium Source : Sélénate de sodium | 55 microgrammes | Not calculated |
| Lutéine Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 2 milligramme | Not calculated |
| Vitamine A Source : Acétate de vitamine A | 1,000 Unités internationales | Not calculated |
| Vitamine A Source : Acétate de vitamine A | 296 mcg EAR | Not calculated |
| Vitamine C Source : Acide ascorbique | 200 milligramme | 200,000 µg |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 27 mg AT | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 60 Unités internationales | Not calculated |
| Zinc Source : Oxyde de zinc | 40 milligramme | 40,000 µg |
| Cuivre Source : Sulfate de cuivre (II) | 2 milligramme | 2,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Silice, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain eyesight, skin, membranes and immune function. Helps in the development and maintenance of night vision. Helps the body to metabolize carbohydrates, fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. Helps to prevent vitamin C deficiency. An antioxidant for the maintenance of good health. Helps to prevent vitamin E deficiency. Helps to maintain healthy skin. Helps to prevent zinc deficiency. Helps to prevent selenium deficiency. Helps to produce and repair connective tissue. Helps to form red blood cells. Helps to prevent copper deficiency. Antioxidant for the maintenance of good health. Antioxidant for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
No statement required.
- Contre-indications
No statement required.
- Effets indésirables connus
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
Source
Official Health Canada record, licence 80067062
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging